LATITUDE secondary analysis - Concurr... - Advanced Prostate...

Advanced Prostate Cancer

22,351 members28,110 posts

LATITUDE secondary analysis - Concurrent use of Abiraterone and NSAIDs - higher risk of Prostate Cancer Specific Mortality and inferior OS

Graham49 profile image
9 Replies

doi.org/10.1200/JCO.2024.42...

”Conclusions: In this secondary analysis, concomitant exposure to 7 classes of medications was not associated with any statistically significant modification of abiraterone effect on OS in de novo high risk mHSPC. Men who received concurrent NSAIDs had a higher risk of PCSM and inferior OS even after adjustment for skeletal metastases burden and pain score. The excess risk of serious cardiovascular adverse events by interaction of abiraterone and exposure to aspirin could be due to reverse causality due to underlying burden of cardiovascular comorbidity in the exposed group.”

Written by
Graham49 profile image
Graham49
To view profiles and participate in discussions please or .
Read more about...
9 Replies
cesanon profile image
cesanon

Is this baby aspirin or heavy duty usage?

JohnInTheMiddle profile image
JohnInTheMiddle

This is very interesting - a follow along analysis to extract more information from the Abiraterone-positive LATITUDE study. I take a baby aspirin everyday because there is some evidence that it helps prevent seeding of new metastases. So reading the note you shared (it's so new it was hard to find anything else) was a concern. However it's hard to understand the logic about "reverse causality" - regarding in the study participants having CVD. Is this a case of Stats 101 "correlation is not causation"?

Maxone73 profile image
Maxone73 in reply toJohnInTheMiddle

The statement suggests that the combination of abi with aspirin was associated with a higher risk of serious cardiovascular events. But, this increase in risk might not be directly caused by the interaction between abi and aspirin. Instead, it could be that the patients who were taking aspirin already had a higher risk of cardiovascular problems to begin with, which is why they were on aspirin.

JohnInTheMiddle profile image
JohnInTheMiddle in reply toMaxone73

I'm so happy you explain this Max. I think I made a post somewhere else on this but I can't remember. Could this be "Stats 101" - "correlation is not causation"? I take a low dose aspirin every day because there is some good research (lab only) that aspirin has a positive effect against metastasis. Apparently it may make it harder for roving cancer cells to successfully find a new home.On the other hand because I'm doing Abiraterone and I wouldn't like to think that I am undermining this fantastic therapy.

Maxone73 profile image
Maxone73 in reply toJohnInTheMiddle

Thinking about aspirin as well but I think 2-3 times per week

tango65 profile image
tango65

No surprise. Chronic NSAIDs including Celebrex may increase blood pressure, damage the kidneys and predispose patients to GI bleeding.

Graham49 profile image
Graham49 in reply totango65

Yes, I have a kidney transplant and I am not allowed to take NSAIDs.

tango65 profile image
tango65 in reply toGraham49

And it gets worse in many patients who received concomitant zoledronic acid for bone mets or osteopenia/malacia which could also affect the kidneys.

Maxone73 profile image
Maxone73 in reply totango65

I was thinking about taking baby aspiring 2-3 per week (the effect as blood thinner lasts for days) but I am on zoledronic acid every 28 days (IV, not oral)...I am having second thoughts

Not what you're looking for?

You may also like...

Simvastatin & Risk of Prostate Cancer Mortality.

New study from Taiwan. "This population-based cohort study demonstrated that statin use...
pjoshea13 profile image

Abiraterone Acetate Plus Prednisone in Newly Diagnosed High-Risk Metastatic Castration-Sensitive Prostate Cancer: Final OS Results

TAKE-HOME MESSAGE •The authors report long-term survival outcomes among patients with newly...
Balsam01 profile image

Abiraterone and Enzalutamide Raise Metabolic, Cardiovascular Adverse Event Risks

Abiraterone was significantly associated with an 84% and 37% increased risk for a major or minor...

Statin Use May Reduce Mortality in High-Risk Prostate Cancer

FRIDAY, Feb. 28, 2020 (HealthDay News) -- Statin use alone or in combination with metformin is...
Balsam01 profile image

Proton Pump Inhibitors and Prostate Cancer-Specific Mortality

A new mostly-Canadian study below [1]. "We identified 21,512 men aged ≥ 66, with a history of a...
pjoshea13 profile image